Lv1
26 积分 2022-02-08 加入
Optimizing KRAS Therapeutics for Non–Small Cell Lung Cancer
6天前
已完结
Response and Resistance to RAS Inhibition in Cancer
6天前
已完结
Unleashing the Power of Covalent Drugs for Protein Degradation
12天前
已完结
Improving outcomes of patients with pancreatic cancer
12天前
已完结
Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges
12天前
已关闭
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
12天前
已完结
Oncogene Mutations: The Shared Antigen Vaccines That Work?
12天前
已完结
Heterocellular crosstalk and architecture of the pancreatic tumour microenvironment
12天前
已完结
DCLK1-mediated regulation of invadopodia dynamics and matrix metalloproteinase trafficking drives invasive progression in head and neck squamous cell carcinoma
23天前
已完结
Emerging landscape of KRAS inhibitors in cancer treatment
27天前
已完结
皖公网安备34019202002308
